A carregar...

Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI

Children with osteogenesis imperfecta (OI) type VI often have high fracture rates despite the current standard treatment with bisphosphonates. Subcutaneous injections of denosumab have been proposed as an alternative treatment approach, but safety data on denosumab in children are limited. Here we d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Musculoskelet Neuronal Interact
Main Authors: Trejo, Pamela, Rauch, Frank, Ward, Leanne
Formato: Artigo
Idioma:Inglês
Publicado em: International Society of Musculoskeletal and Neuronal Interactions 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881132/
https://ncbi.nlm.nih.gov/pubmed/29504582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!